e-learning
resources
Virtual 2020
Pre-Congress Content
Clinical data and COPD management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit
X. Chen (Melbourne, Australia), N. Smallwood (Melbourne, Australia)
Source:
Virtual Congress 2020 – Clinical data and COPD management
Session:
Clinical data and COPD management
Session type:
E-poster session
Number:
997
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
X. Chen (Melbourne, Australia), N. Smallwood (Melbourne, Australia). Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit. 997
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Polypharmacy in patients hospitalised for acute exacerbation of COPD
Source: Eur Respir J 2014; 44: 791-794
Year: 2014
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Gender differences in hospitalized patients with acute exacerbation of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
The effects of real-time telemedicine consultations between hospital-based nurses and severe COPD patients discharged after exacerbation admissions
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013
Cognitive impairment in patients hospitalized with acute COPD exacerbation
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in COPD and asthma
Year: 2014
Outpatient care for reducing readmissions of patients hospitalized for exacerbation of COPD
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Characteristics and medication use of the patients with acute exacerbations of asthma-COPD overlap syndrome
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Polypharmacy in patients with acute exacerbation of COPD
Source: Annual Congress 2011 - COPD management
Year: 2011
Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
The rationality of the use of NIV in elderly patients with acute COPD exacerbation
Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure
Year: 2018
Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
One year experience with acute COPD assessment service (ACAS) for patients with acute exacerbations of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 178s
Year: 2006
Variability in clinical practice for chronic obstructive pulmonary disease in outpatient clinics
Source: International Congress 2015 – Different data in COPD
Year: 2015
Effectiveness of self-treatment of exacerbations in COPD patients: Two-year follow-up of the COPE-II study
Source: International Congress 2014 – Best abstracts in rehabilitation and chronic care (sponsored by MOTEK Medical)
Year: 2014
Physical therapy effects on psychological functions in patients with acute COPD exacerbation
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment methods in COPD and asthma
Year: 2013
Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept